This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Astra. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Silvana Consolo: Innovator in Galanin Antagonist Research
Introduction
Silvana Consolo is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmacology, particularly through her research on galanin antagonists. Her innovative work has led to the development of new peptides that have potential therapeutic applications.
Latest Patents
Silvana Consolo holds a patent for a galanin antagonist, which is a galanin receptor ligand. The patent describes new peptides, including Galanin (1-12)-Pro-Substance P(5-11), Galanin (1-12)-Pro-Bradykinin(2-9), Galanin (1-12)-Pro-Pro-Pro-(Leu.sup.5 -Enkephalin (5-1), and Galanin (1-12)-Pro-Lys(.epsilon.-NH-)Pro-(Leu5-Enkephalin (5-1). These peptides and their functional analogues are utilized in pharmaceutical preparations to treat disorders in mammals that depend on the physiological function of galanin at the galanin receptor. Silvana has 1 patent to her name.
Career Highlights
Silvana Consolo has built a successful career in the pharmaceutical industry. She is currently associated with Aktiebolaget Astra, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of galanin's role in various physiological processes.
Collaborations
Throughout her career, Silvana has collaborated with notable scientists, including Tamas Bartfai and Tomas H Okfelt. These collaborations have enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Silvana Consolo is a distinguished inventor whose work on galanin antagonists has the potential to impact therapeutic approaches in medicine. Her innovative research and collaborations highlight her commitment to advancing pharmacological science.